1Freeman DJ, Norrie J, Caslake MJ, et al.C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study [J].Diabetes,2002,51(5):1596-1600.
2Vozarova B, Weyer C, Lindsay RS, et al. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes [J].Diabetes,2002,51(2):455-461.
3Andreas F,Ralph DA,George H,et al.Chronic subclinical inflammation as part of the insulin resistance syndrome [J].Circulation,2000,102(1):42-47.
4Ridker PM, Hernnekens CH, Buring JE, et a1.C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J].N Ensi JMed,2002,342(12):836-843.
5Festa A, D Agostino R Jr,Tracy RP,et a1.Elevatedlevels of acute_phase proteins and plasminogen activator inhabitorl-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study[J].Diabetes,2002,51:1 131-1 137.
7Spranger J, Kroke AM. Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes: Results of the Prospective population-Based European Prospective Investigation into Cancerand Nutrition(EPIC). Potsdamstudy[J]. Diabetes, 2003, 52(3):812-817.
8Wanten C, Van Emst-de Vriess, Naber T, et al. Nutritional lipid emulsions modulate cellular signaling and activation of human neutrohils[J]. J Lipid Res,2001,42(3):428-436.
二级参考文献20
1Duclos T W. Function of c-reactive protein [J]. Ann Med, 2000,32:274-278.
2Volanakis J E. Human c-reactive protein: expression,structure, and function [J]. Mol Immunol,2001,38:189-197.
3Ford E S. Body mass index, diabetes, and c-reactive protein among U S adults [J]. Diabetes Care,1999,22:1971-1977.
4Barzilay J I, Abraham L, Heckbert S R, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study[J]. Diabetes,2001,50:2384-2389.
5Pickup J C, Crook M A. Is type 2 diabetes mellitus a disease of the innate immune system? [J].Diabetologia, 1998,41:1241-1248.
6Pickup J C, Mattock M B, Chusney G D, et al.NIDDM as a disease of the innate immune system:association of acute phase reactants and interleukin-6 with metabolic syndrome X [ J]. Diabetologia, 1997,40:1286-1292.
7Pradhan A D, Manson J E, Rifai N, et al. C-reactive protein,interleukin 6,and risk of developing type2 diabetes mellitus [J]. JAMA,2001,286:327-333.
8Festa A, Agostno R D, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome [J]. Circulation, 2000,102:42-47.
9Oaes O N, Akca H, Nayo L D, et al. A phosphatidylinositol 3 - Kinase / Akt / mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-l[J]. Proc Natl Acad Sci USA,2001,10:4640-4645.
10John A, Colwell M D. Inflammation and diabetic vascular complications [J]. Diabetes Care, 1999,22:1927-1928.
